Sami Corwin
Stock Analyst at William Blair
(4.82)
# 448
Out of 4,361 analysts
401
Total ratings
59.8%
Success rate
20.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $28.66 | - | 9 | May 26, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | n/a | $293.21 | - | 18 | May 18, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | n/a | $2.05 | - | 25 | May 14, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $3.68 | - | 26 | May 14, 2026 | |
| NGNE Neurogene | Maintained: Buy | n/a | $26.14 | - | 22 | May 13, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $6.58 | - | 19 | May 13, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | n/a | $7.90 | - | 10 | May 13, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | n/a | $10.88 | - | 14 | May 7, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $24 → $32 | $28.96 | +10.50% | 29 | May 7, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | n/a | $52.02 | - | 18 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $20.26 | -7.45% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.25 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.89 | - | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $53.32 | - | 13 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.23 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.78 | - | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $26.76 | - | 29 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.79 | - | 15 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.28 | - | 18 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.91 | - | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.17 | - | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.52 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.69 | n/a | 4 | Feb 1, 2023 |
Tyra Biosciences
May 26, 2026
Maintained: Buy
Price Target: n/a
Current: $28.66
Upside: -
Krystal Biotech
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $293.21
Upside: -
Allogene Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $2.05
Upside: -
Cabaletta Bio
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $3.68
Upside: -
Neurogene
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $26.14
Upside: -
Solid Biosciences
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $6.58
Upside: -
Kyverna Therapeutics
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $7.90
Upside: -
Zevra Therapeutics
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $10.88
Upside: -
Beam Therapeutics
May 7, 2026
Reiterated: Buy
Price Target: $24 → $32
Current: $28.96
Upside: +10.50%
CRISPR Therapeutics AG
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $52.02
Upside: -
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $20.26
Upside: -7.45%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.25
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $2.89
Upside: -
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $53.32
Upside: -
Feb 20, 2026
Maintained: Buy
Price Target: n/a
Current: $68.23
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: n/a
Current: $21.78
Upside: -
Feb 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $26.76
Upside: -
Jan 9, 2026
Maintained: Buy
Price Target: n/a
Current: $0.79
Upside: -
Nov 12, 2025
Maintained: Hold
Price Target: n/a
Current: $36.28
Upside: -
Nov 11, 2025
Maintained: Hold
Price Target: n/a
Current: $2.91
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $2.17
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $14.52
Upside: n/a
Feb 1, 2023
Maintained: Buy
Price Target: n/a
Current: $5.69
Upside: n/a